Biotech Company Mistakenly Informs 400 Patients They May Have Cancer
TL;DR
Grail, the maker of a blood test for cancer, has acknowledged that around 400 of its customers were mistakenly told last month that they might have the disease due to a software configuration issue from one of its vendors. The problem was not caused by inaccurate test results, and more than half of the people who received the letter in error had not yet had their blood drawn for the test. The vendor, PWNHealth, said it addressed the underlying problem within an hour of becoming aware of it and has implemented additional processes to ensure it does not happen again.
- Hundreds Were Mistakenly Told They Might Have Cancer, Test Company Says The New York Times
- Grail Says About 400 Patients Incorrectly Informed They May Have Cancer HuffPost
- Blood-Test Customers Mistakenly Told They May Have Cancer The Wall Street Journal
- Around 400 patients were wrongly informed they might have cancer, biotech company says Yahoo! Voices
- Biotech company mistakenly tells 400 they may have cancer NewsNation Now
Want the full story? Read the original reporting
Read on The New York Times